a subtle dysfunction (expression) of the FGFR1, SOS1 and RAF1 genes is involved in the development of the most common male reproductive tract disorder -unilateral or bilateral cryptorchidism.
Introduction
Cryptorchidism is the most frequent disorder of the urogenital tract in males. It is associated with important consequences in adulthood, such as infertility and testicular cancer. Androgens are key hormones involved in the completion of epididymo-testicular descent; therefore, impaired fetal androgen action can result in cryptorchidism. However, the underlying mechanism by which impaired androgen action produces 'isolated' cryptorchidism is still debatable [1] . Furthermore, fibroblast growth factor receptor 1 (FGFR1) gene mutations Hadziselimovic 354 can cause both Kallmann syndrome and/or idiopathic hypogonadotropic hypogonadism, that are frequently associated with cryptorchidism [2] . Androgen-independent events may also be responsible for testicular descent. Insulin-like factor 3 (INSL3), and its receptor, relaxin family peptide receptor 2 (RXFP2, also called LGR8, leucine-rich repeat-containing GPCR, or GREAT, G-protein-coupled receptor), are possible regulators of testicular descent that may be responsible for isolated cryptorchidism [3] ; although mutations in the INSL3 and RXFP2 genes have rarely been associated with human cryptorchidism. Overall, the frequency of INSL3 and RXFP2 mutations is 7/600 at birth (1.2%) and 7/303 (2.3%) in persistently cryptorchid males, with a higher prevalence in bilateral forms (5/120, 4 .2%) than in unilateral forms (1/183, 0.5%) [3, 4] . In addition, cryptorchidism may be associated with a specific haplotype of the gene for estrogen receptor-␣ (ESR1), which mediates the estrogenic effects of environmental endocrine disrupters (EEDs). The effects of EEDs on testicular descent might depend on an individual's genetic susceptibility [5] . Epididymo-testicular descent is a process where both testis and epididymis descend from dorsal abdominal wall into the scrotum and in humans this process is accomplished at birth. 1-3% of epididymides and testes remain undescended and require treatment. Hormonal therapy generally around second birthday is successful in 20-60% depending on the undescended position of both organs. We hypothesize that undescended testis has different gene expression pattern compared to descended one. Therefore, we analyzed gene expression with Affymetrix method for all the genes known to be involved in epididymo-testicular descent.
Patients and Methods

Testicular Biopsies and Pooling of Patients
In our institutions, it is routine practice to perform testicular biopsy during surgery for undescended testis. We have found that testicular biopsy provides useful information about future semen quality and helps to identify patients with atypical spermatogonia or carcinoma in situ. Cryptorchid testis was defined as a testis localized outside the scrotum and incapable of being brought into a stable scrotal position. Th e age of the patients at surgery ranged from 10 months to 4.5 years.
The contralateral descended testes from patients with testicular agenesis have been shown to have more Leydig and germ cells and a higher rate of transformation of Ad spermatogonia into spermatocytes than the contralateral descended testes of patients with unilateral cryptorchidism [6] . Not all contralateral testes in patients with testicular agenesis are expected to have normal histology and may require subsequent hormonal treatment [6] . Therefore, we routinely biopsy these testes during the period of testicular fixation performed in order to prevent testicular torsion.
Twenty-two testicular biopsies (as large as the size of a kernel of rice) from 20 boys were analyzed (16 testes from boys with cryptorchidism and 6 contralateral descended testes; 2 from boys with undescended testis and 4 from patients with testicular agenesis). All contralateral testes were selected for normal histology according to age. The mean age of the patients at surgery was 3.2 years and for the controls 3.8 years. All patients had an extensive clinical examination, and we could not find any clinical signs of developmental malformations or syndromes, none had hypospadias. In particular, no clinical sign for Kallmann syndrome was observed. Furthermore, all patients had normal thyroid screening and no features of hypopituitarism were discernible. Testicular position at surgery was one abdominal, one inguinal and 14 at tubercle.
Biopsies were fixed in 3% glutaral dehyde and embedded in Epon. Semi-thin sections, 1 m thick, were examined by Zeiss Axioscope phase contrast and conventional light microscope (Plan-Apochromat 63 ! /1.40 oil).
Photographs were performed with a Canon power-shot camera. For each biopsy, at least 200 tubular cross-sections were evaluated. Immediately following biopsy, one half of each biopsy sample was collected for RNA isolation and GeneChip hybridization, and was stored in cold 1 ! phosphate-buffered saline (PBS). The tissue was then filtered through 100-nm nylon gauze. Fractions were collected, washed three times in 1 ! PBS, and snap-frozen in liquid nitrogen prior to storage at -80 ° C. An aliquot of each fraction was fixed in 1 ! PBS containing 1% formaldehyde (Polio, France) and 1% fetal calf serum (Eurabbie, France) and analyzed by DNA flow cytometry to determine its relative DNA content. Cell pellets and tissues were sheared in RLT buffer (Qiagen) supplemented with 1% ␤ -mercaptoethanol and further processed using a Qiashredder (Qiagen). The suspension was centrifuged for 2 min at maximum speed and the clarified lysate was stored at -80 ° C. Total RNA isolation was performed using RNeasy Mini-Spin columns (Qiagen) according to standard protocols. RNA quality was monitored using RNA Nano 6000 Chips and the 2100 BioAnalyzer (Agilent). cRNA synthesis, human U133 plus 2.0 GeneChip hybridization and raw data recovery were carried out as published previously [7] . Raw data files are available at the EBI ArrayExpress repository [8] via the accession numbers ETABM-130 and E-TABM-174 and GEO.
Statistical Analysis and Interpretation of Microarray Data
Data analysis and gene filtering were performed using R/Bioconductor [9] . Signal condensation was performed using only the RMA from the Bioconductor Affy package. Differentially expressed genes were indentified using the empirical Bayes method (Ftest) implemented in the LIMMA package and adjusted with the false discovery rate method [10] . We selected those probe sets with a Log2 average contrast signal of at least 5, an adjusted p value ! 0.05 and an absolute Log2 fold change of 1 0.585 (1.5fold in linear space). Hierarchical clustering and visualization were performed in R.
Quantitative Real-Time PCR
Quantitative real-time PCR (qRT-PCR) was performed using a Corbett Research RG-6000 instrument. cDNAs were synthesized with Reverse Transcriptase -Core Kit (Eurogentec, cat.
No. RT-RTCK-03) using random primers. Real-time PCR runs were performed using SyBr Fast Kit (Kapa Biosystems, cat. No. KK4602) with each gene-specific primer at 200 n M final concentration in a total volume of 17.5 l. Length waves of source and detection were set at 470 and 510 nm, respectively. Gain was set at 8.33. PCR program was set as follows: 95 ° C for 60 s -45 ! (95 ° C for 3 s, 60 ° C for 10 s, 72 ° C for 4 s) followed by a melting curve analysis (65-95 ° C, rising by 0.65 ° C in each step) to attest amplification specificity. Threshold cycles (crossing point) were determined using Rotor-Gene software version 6.1. Good PCR efficiency was checked by performing a dilution series of the cDNA. Minus RT controls were performed for each sample studied. Threshold cycles (crossing point) were determined using Rotor-Gene software version 6.1. Expression levels were normalized to TFRC1 and GAPDH using a geometric mean of their level of expression. Those genes were selected because they showed minimum variation between individual samples (both on microarrays and by qPCR). Fold differences were calculated using the deltadelta Ct method.
Antibody Validation
We wanted to determine whether greater transcript expression corresponded to greater protein expression. Immunoperoxidase histochemistry, although not a quantitative method, is currently the only practical way to detect proteins in small fixed tissue samples. We employed ten antibodies to proteins known to be involved in the reproductive hormonal axis.
For immunohistochemical analysis, Epon was removed from the tissue sections. The sections were treated with 2% bovine serum albumin to reduce non-specific binding and then incubated with primary antibody overnight at 4 ° C. All samples were washed with PBS between incubations. We validated ten antibodies ( table 1 ).
Secondary antibodies, labeled with polymer-horseradish peroxidase [goat polyclonal anti-rabbit IgG, mouse IgG and IgM (prediluted; ab2891); Abcam, Cambridge, UK] were used to detect binding of the primary antibody. The chromogenic reaction was developed by adding a freshly prepared solution of 3,3-diaminobenzidine solution (DAB + chromogen; DAKO). The DAB reaction was terminated by washing in TRIS-buffered saline (TBS 0.05 M and 0.85 M NaCl, ph 7.6). To visualize the histology of tes-ticular cells, the samples were counterstained with toluidine blue. Antibody binding was indicated by a brown precipitate. Different cell types were identified on the basis of their nuclear morphology and position within the developing gonad. Immunohistochemistry experiments were performed at least twice on at least 4 patients from each group, and only those with identical results between experiments for each sample were considered acceptable. Controls for nonspecific binding of the secondary antibody were performed in all experiments by omitting the primary antibody; these consistently yielded no signal within the seminiferous epithelium or the interstitial space. The interstitial staining observed in the presence of the primary antibody was considered to be nonspecific because it was not associated with, or localized within, a particular cell type. However, staining of interstitial cells was recorded. Experimental design, biomaterials and treatments, reporters, staining, imaging data, and image characterization were performed in compliance with the minimum information specification for immunohistochemistry experiments [11] .
Ethical Considerations and Approval
In accordance with the Declaration of Helsinki, the Institutional Review Board of Kindertagesklinik Liestal approved all aspects of this study. Approval was provided for research involving the use of material (data records or specimens) that had originally been collected for non-research purposes.
Results
The total RNA and cRNA samples were of high quality, the signal intensity distributions were similar and were within the normal range. Figure 1 shows the heat map resulting from the visualized signal intensities, 3,688 transcripts were differentially expressed in the cryptorchid and descended testes after statistical filtering (fold change 1 1.5, adjusted p value ! 0.05). This gene list was composed of 1,822 elevated and 1,866 decreased transcripts in the cryptorchid testes. Our particular interest was to investigate the expression profiles of genes that had previously been shown to be associated with cryptorchidism, namely: INSL3, RXFP2/LGR8/GREAT, NR4A1, NR5A1, CYP19, NROB1/ DAX1/AHC, KAL1, GNRHR, PROK2, LHB, ESR1, SOX2, GPR54, and HOXA10 ( table 2 ). We found INSL3 was expressed equally in descended and undescended testes. Furthermore, analysis of the expression pattern of the gene for the INSL3 receptor, RXFP2 , also called LGR8 or GREAT , showed no differences between the two groups studied ( table 2 ). Low, not significantly different expression was found in both groups for CYP19A1 , GNRHR , PROK2 , SOX2, KISS1R ( GPR54 ), and HOXA10 ( table 2 ). No differences were observed in the signaling intensity of NR4A1 , NR5A1 , NROB1/DAX1/AHC , KAL1 , LHB , and ESR1 ( table 2 ). Our main finding was that cryptorchid testis displayed reduced expression of FGFR1 , as well as RAF1 and SOS1 , known to be part of its signaling pathway ( table 3 ) .
Immunohistochemical and qRT-PCR Validation
Immunoperoxidase histochemistry, although not a quantitative method, is currently the only practical way to detect proteins in small fixed tissue samples. To determine whether transcript expression corresponded to protein expression, several antibodies were employed and the histological sections of both groups were compared. The proteins EGR4, MAGE4, ALDH1, and COL4A3 were expressed in the spermatogonia of both groups ( fig. 2 ). Identical cytoplasmic localization was found for all other proteins analyzed. In addition to its expression in germ and Leydig cells, CBL was expressed in Sertoli cells. Fgfr1 expression was observed in cytoplasm of the germ and Leydig cells ( fig. 3 ). We validated our microarray data by qRT-PCR on four genes that showed significant expression changes, all of which showed high correlation in the obtained transcriptional profiles ( fig. 4 ).
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Discussion
The hypothalamo-pituitary-gonadal axis (HPG) regulates the development and the endocrine and reproductive functions of the gonads throughout all phases of life. Several animal models of hypogonadotropic hypogonadism are associated with cryptorchidism. (1) HPG male mice lacking GnRH are cryptorchid, but have a normal gubernaculum, and their testes develop and descend normally if treated with gonadotropins [12] . (2) Pask et al. [13] reported a GnRH receptor (GnRHr) gene loss-of-function mutation in male mice that caused hypogonadotropic hypogonadism during N-ethyl-N -nitrosourea mutagenesis screening. Affected males had a micropenis, undescended testes, and were infertile. (3) Luteinizing hormone receptor (LHR) knockout male mice showed undescended testes, small testis, underdeveloped scrotum, small penis, and arrested spermatogenesis [14, 15] . Cryptorchidism in LHR knockouts was caused by developmental defects of gubernaculum because of testosterone deficiency, and testosterone replacement therapy reversed all morphologic and gene expression changes except INSL3 , suggesting that testosterone secreted by Leydig cells facilitates the completion of testicular descent [15] . These knockout male mice had inguinoscrotal testes, suggesting the HPG axis is distributed in the inguinoscrotal phase of testis descent [15] .
The FGFR1 signaling pathway regulates cell proliferation, migration, differentiation, and survival; accordingly, it is essential for various phases of human development [16] . Mutations of the FGFR1 gene have been described in cases of idiopathic hypogonadotropic hypogonadism with functioning olfactory bulb and normal sense of smell [2, 17] . Pitteloud et al. [17] described that FGFR1 was critical not only for the migration of GnRH neurons across the olfactory tracts, but also demonstrated that an entirely different mechanism must exist for the failure of GnRH in those cases with normal olfactory bulbs, tracks, and senses of smell [18] . This phenotypic complexity suggested FGFR1 mutations, in addition to presumably playing a critical role in GnRH neuronal maturation, may be associated with neuronal survival and possibly apoptosis in normosmic idiopathic hypogonadotropic hypogonadism patients with FGFR1 mutations [19] .
Leydig cell atrophy was observed in all undescended testes ( fig. 3 , 4 ) . This atrophy is a consequence of hypogonadotropic hypogonadism [20, 21] . Furthermore, low number of germ cells and particularly impaired germ cell differentiation is a further evidence of impaired gonadal maturation after birth, also denominated mini-puberty ( fig. 3 , 4 ) [20, 21] . Furthermore, FGFR1 affects the proliferation and migration of vascular smooth muscle cells [22] and is involved in myoblast proliferation and differentiation [23] . Inhibited muscle development was observed in the epididymis and scrotal anlage in INSL3 mutant mice [24] [25] [26] . Reduced expression of FGFR1 has not been described before in association with isolated cryptorchidism. Nevertheless, mediators of the FGFR1 signaling pathway, SOS1 and RAF1, have been associated with leopard syndrome and Noonan syndrome [27] , syndromes that include cryptorchidism. Theoretically, the reduced gene expression of FGFR1 and its mediators, SOS1 and RAF1 , could affect muscle development and, therefore, cause crypto-epididymis.
Recently, Ferlin et al. [3] determined the frequency of genetic alterations such as karyotype anomalies and INSL3 , LGR8 / GREAT , and AR gene mutations in cryptorchidism in their large study. They reported that the overall frequency of genetic alterations was significantly higher in boys with cryptorchidism (5.3%) than in controls (0.3%). As a result, the odds ratio for the association of cryptorchidism with genetic alterations was 16.7, indicating a significant association between cryptorchidism and genetic alterations. In more than 2,000 patients and controls analyzed to date, the T222P RXFP2 mutation is the only mutation strongly associated with the mutant phenotype. INSL3 production is also related to LH [2] ;
although INSL3 apparently has a great effect in mouse models, it remains unclear what role it plays in the testicular descent of humans. Analyses of mutations of INSL3 , as well as LGR8/GREAT genes, in boys with either unilateral or bilateral cryptorchidism revealed only a small percentage to have sequence changes of functional significance. Our examinations showed no differences in the gene expression profiles of INSL3 or LGR8 between subjects with descended and cryptorchid testes. In all of the boys we examined, the transabdominal phase had been completed. This could explain why we could not find a difference in expression of INSL3 .
We could not find significant differences between descended and undescended testis with respect to the 14 genes described as being involved in cryptorchidism development. This may be because these genes were found associated either with pronounced androgen deficiency ( NR5A1 , NR4A1 , and CYP19 ) or with classical hypogonadotropic hypogonadism ( GNRHR , KAL1 , LHB , and PROK2 ).
In conclusion, mutations of the FGFR1 gene induce idiopathic hypogonadotropic hypogonadism. A subtle dysfunction of the FGFR1 gene, observed here in cryptorchid testes, may be responsible for unilateral or bilateral epididymo-testicular arrest along the descent path into the scrotum.
